Back to search results
NCT05755945

A Study of Wearable Devices to Predict Migraines

Enrolling by Invitation
NAAges 18+InterventionalPrevention
Mayo Clinic
~20 participants
Updated 2026-06-01 on ClinicalTrials.gov
What's tested:eHealth Application

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percentage accuracy of fit with AUC of the ROC (receiver operating characteristics) curve (%) for headache tracking.
Measured over 6 months

Conditions

Migraine

Explore related trials

Migraine

Where it's being run

1 sites across 1 states
Minnesota1

Study leadership

  • Naraya Kissoon, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 years and older (no upper age limit defined)
History of chronic migraine as defined by the International Headache Society's International Classification of Headache Disorders (3rd edition).
Response to current preventative therapy with ≥ 50% improvement in the frequency of headache days when compared to baseline
4 to 14 average number of total headache days per month during peak efficacy of preventative therapy
Ability to understand study procedures and to comply with them for the entire length of the study and use study devices as outlined in protocol.
Patient agrees to maintain a daily electronic headache diary.
Proficient in the use of electronic devices including Apple HomeKit and Apple Watch. - Subjects owns an iPhone with iOS 16 or later operating system installed on iPhone. Apple watch series 8 with watch OS6 or later will be provided by the study.

Exclusion

Chronic daily headache with no periods of headache freedom.
≥ 15 average number of headaches days per month during peak efficacy of preventative treatment.
Medication overuse headache as defined by the International Headache Society's International Classification of Headache Disorders (3rd edition).
Daily opioid use for \> 3 months (e.g., hydrocodone, oxycodone, fentanyl patch) or other daily analgesic use for chronic pain disorders (e.g., NSAIDS or acetaminophen).
Inability or unwillingness of individual or legal guardian/representative to give written informed consent.

What this trial measures

  • Percentage accuracy of fit with AUC of the ROC (receiver operating characteristics) curve (%) for headache tracking.6 months

    Percentage accuracy of fit with AUC of the ROC curve for factors from data collected from custom phone app integrated with smart devices to track headache frequency and severity.